Recombinant Human R-Spondin 3 Protein
Recombinant Human R-Spondin 3 Protein Summary
Product Specifications
Gln22-His272
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
3500-RS
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS containing at least 0.1% of human or bovine serun albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
3500-RS/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
Recombinant human R-Spondin 3 (Catalog # 3500-RS) has a molecular weight (MW) of 36.1 kDa as analyzed by SEC-MALS, suggesting that this protein is a monomer. MW may differ from predicted MW due to post-translational modifications (PTMs) present (i.e. Glycosylation).
Recombinant Human R-Spondin 3 (Catalog # 3500-RS), in the presence of Recombinant Mouse Wnt 3a (Catalog # 1324-WN; 5 ng/mL), induces activation of beta-catenin in HEK293T cells measured using the Topflash assay. The ED50 for this effect is 0.50-2.00 ng/mL.
The lot-to-lot consistency of Recombinant Human R-Spondin 3 (Catalog # 3500-RS) was assessed by testing the ability of three independent lots of the protein to stimulate activation of beta-Catenin using a TOPflash beta-Catenin/TCF reporter assay in the HEK293T human kidney cell line, in the presence of 5 ng/mL Recombinant Mouse Wnt-3a (1324-WN). Each trace on the graph represents data obtained from Recombinant Human R-Spondin 3 from a different manufacturing run. The ED50 for this effect is 0.500-2.00 ng/mL in the presence of 5 ng/mL Recombinant Mouse Wnt-3a.
Reconstitution Calculator
Background: R-Spondin 3
R-Spondin 3 (RSPO3, roof plate-specific spondin 3), also called cysteine-rich and single thrombospondin domain containing-1 (Cristin 1), is an ~31 kDa secreted protein that shares ~40% amino acid (aa) identity with the other three R-Spondin family members (1, 2). All are positive modulators of Wnt/ beta -catenin signaling, but each has a distinct expression pattern (1-4). Like other R-spondins,R-Spondin 3 contains two adjacent cysteine-rich furin-like domains (aa 35-135) with one potential N-glycosylation site (aa 36), followed by a thrombospondin (TSP-1) motif (aa 147-207) and a region rich in basic residues (aa 211-269). Only the furin-like domains are needed for beta -catenin stabilization (2). Within aa 21-209, human R-Spondin 3 shares 93%, 92%, 97%, 96% and 92% aa identity with mouse, rat, equine, bovine and canine R-Spondin 3, respectively. Potential isoforms of 279 and 297 aa diverge at aa 210 and 276, respectively (5). Mouse R-Spondin 3 is critical for development of the placental labyrinthine layer, probably by promoting VEGF expression and thus vascular development (6, 7). It is also essential for expression of the placenta-specific transcription factor, Gcm1. In the mouse embryo, R-Spondin 3 is often expressed by or located near endothelial cells (6). It is found in the roof plate, tail, somites, otic vesicles, cephalic mesoderm, truncus arteriosus, atrioventricular canal of the developing heart, and strongly but transiently in developing limbs (4, 7). R-Spondins regulate Wnt/ beta -catenin by competing with the Wnt antagonist DKK-1 for binding to the Wnt co-receptors LRP-6 and Kremen, reducing their DKK-1-mediated internalization (8, 9). Reports differ on whether R-Spondins bind LRP-6 directly (8-10). R-Spondin 3 has also been identified as an oncogene (11).
- Chen, J-Z. et al. (2002) Mol. Biol. Rep. 29:287.
- Kim, K.-A. et al. (2008) Mol. Biol. Cell 19:2588.
- Hendrickx, M. and L. Leyns (2008) Develop. Growth Differ. 50:229.
- Nam, J.-S. et al. (2007) Gene Expr. Patterns 7:306.
- Entrez Accession # EAW48114 and EAW48116.
- Kazanskaya, O. et al. (2008) Development 135:3655.
- Aoki, M. et al. (2007) Dev. Biol. 301:218.
- Binnerts, M.E. et al. (2007) Proc. Natl. Acad. Sci. USA 104:14700.
- Nam, J.-S. et al. (2006) J. Biol. Chem. 281:13247.
- Wei, Q. et al. (2007) J. Biol. Chem. 282:15903.
- Theodorou, V. et al. (2007) Nat. Genet. 6:759.
Citations for Recombinant Human R-Spondin 3 Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
17
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
R-spondin 3 deletion induces Erk phosphorylation to enhance Wnt signaling and promote bone formation in the appendicular skeleton
Authors: K Nagano, K Yamana, H Saito, R Kiviranta, AC Pedroni, D Raval, C Niehrs, F Gori, R Baron
Elife, 2022-11-02;11(0):.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt target genes
Authors: G Pizzolato, L Moparthi, S Söderholm, C Cantù, S Koch
Journal of Cell Science, 2022-10-10;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Cell Culture -
Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids
Authors: JF Dekkers, EJ van Vliet, N Sachs, JM Rosenbluth, O Kopper, HG Rebel, EJ Wehrens, C Piani, JE Visvader, CS Verissimo, SF Boj, JS Brugge, H Clevers, AC Rios
Nature Protocols, 2021-03-10;0(0):.
Species: Human
Sample Types: Organoid
Applications: Bioassay -
Development of a human primary gut-on-a-chip to model inflammatory processes
Authors: C Beaurivage, A Kanapeckai, C Loomans, KS Erdmann, J Stallen, RAJ Janssen
Scientific Reports, 2020-12-08;10(1):21475.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro
Authors: NY Loh, JEN Minchin, KE Pinnick, M Verma, M Todor?evi?, N Denton, JE Moustafa, JP Kemp, CL Gregson, DM Evans, MJ Neville, KS Small, MI McCarthy, A Mahajan, JF Rawls, F Karpe, C Christodou
Nat Commun, 2020-06-03;11(1):2797.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
Authors: X Li, B Pan, X Song, N Li, D Zhao, M Li, Z Zhao
Cancer Cell Int., 2020-03-18;20(0):86.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs
Authors: M Zhang, M Haughey, NY Wang, K Blease, AM Kapoun, S Couto, I Belka, T Hoey, M Groza, J Hartke, B Bennett, J Cain, A Gurney, B Benish, P Castiglion, C Drew, J Lachowicz, L Carayannop, SD Nathan, J Distler, DA Brenner, K Hariharan, H Cho, W Xie
PLoS ONE, 2020-03-11;15(3):e0229445.
Species: Human
Sample Types: Whole Cells
Applications: IHC Control -
A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion
Authors: PG Boone, LK Rochelle, JD Ginzel, V Lubkov, WL Roberts, PJ Nicholls, C Bock, ML Flowers, RJ von Furste, BR Stripp, P Agarwal, AD Borowsky, RD Cardiff, LS Barak, MG Caron, HK Lyerly, JC Snyder
Nat Commun, 2019-12-02;10(1):5490.
Species: Human
Sample Types: Whole Cells
Applications: Cell Culture -
Differential activities and mechanisms of the four R-Spondins in potentiating Wnt/?-catenin signaling
Authors: S Park, J Cui, WA Yu, L Wu, K Carmon, QJ Liu
J. Biol. Chem., 2018-05-11;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
R-spondins can potentiate WNT signaling without LGRs
Authors: AM Lebensohn, R Rohatgi
Elife, 2018-02-06;7(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Exercise-Induced Skeletal Muscle Adaptations Alter the Activity of Adipose Progenitor Cells
Authors: D Zeve, DP Millay, J Seo, JM Graff
PLoS ONE, 2016-03-25;11(3):e0152129.
Species: Primate - Chlorocebus pygerythrus (Vervet Monkey)
Sample Types: Whole Cells
Applications: Bioassay -
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates beta-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.
Authors: Chartier C, Raval J, Axelrod F, Bond C, Cain J, Dee-Hoskins C, Ma S, Fischer M, Shah J, Wei J, Ji M, Lam A, Stroud M, Yen W, Yeung P, Cancilla B, O'Young G, Wang M, Kapoun A, Lewicki J, Hoey T, Gurney A
Cancer Res, 2015-12-30;76(3):713-23.
Species: Mouse
Sample Types: In Vivo
Applications: Bioassay -
RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.
Authors: Carmon K, Gong X, Yi J, Thomas A, Liu Q
Proc Natl Acad Sci U S A, 2014-03-17;111(13):E1221-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
Authors: Wu C, Qiu S, Lu L, Zou J, Li W, Wang O, Zhao H, Wang H, Tang J, Chen L, Xu T, Sun Z, Liao W, Luo G, Lu X
Nat Commun, 2014-01-01;5(0):3149.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin.
Authors: Xie, Yang, Zamponi, Raffaell, Charlat, Olga, Ramones, Melissa, Swalley, Susanne, Jiang, Xiaomo, Rivera, Daniel, Tschantz, William, Lu, Bo, Quinn, Lisa, Dimitri, Chris, Parker, Jefferso, Jeffery, Doug, Wilcox, Sheri K, Watrobka, Mike, LeMotte, Peter, Granda, Brian, Porter, Jeffrey, Myer, Vic E, Loew, Andreas, Cong, Feng
EMBO Rep, 2013-10-29;14(12):1120-6.
Species: Human
Sample Types: Whole Cells
Applications: Cell Culture -
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Authors: Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J
Nature, 2012-07-26;487(7408):505-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
Authors: Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H, Mao X, Ma Q, Zamponi R, Bouwmeester T, Finan PM, Kirschner MW, Porter JA, Serluca FC, Cong F
Nature, 2012-04-29;485(7397):195-200.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human R-Spondin 3 Protein
There are currently no reviews for this product. Be the first to review Recombinant Human R-Spondin 3 Protein and earn rewards!
Have you used Recombinant Human R-Spondin 3 Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image